Torekov Signe S.
Torekov Signe S.
University of Copenhagen, Department of Biomedical Sciences
Bekræftet mail på sund.ku.dk
Citeret af
Citeret af
Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation
CH Andreasen, KL Stender-Petersen, MS Mogensen, SS Torekov, ...
Diabetes 57 (1), 95-101, 2008
Impact of postprandial glycaemia on health and prevention of disease
EE Blaak, JM Antoine, D Benton, I Björck, L Bozzetto, F Brouns, ...
Obesity reviews 13 (10), 923-984, 2012
GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study
K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ...
Diabetes 64 (7), 2513-2525, 2015
An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the future
S Madsbad, U Kielgast, M Asmar, CF Deacon, SS Torekov, JJ Holst
Diabetes, Obesity and Metabolism 13 (5), 394-407, 2011
Proteomics reveals the effects of sustained weight loss on the human plasma proteome
PE Geyer, NJ Wewer Albrechtsen, S Tyanova, N Grassl, EW Iepsen, ...
Molecular systems biology 12 (12), 901, 2016
Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
K Færch, D Vistisen, G Pacini, SS Torekov, NB Johansen, DR Witte, ...
Diabetes 65 (11), 3473-3481, 2016
GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women
EW Iepsen, JR Lundgren, B Hartmann, O Pedersen, T Hansen, ...
The Journal of Clinical Endocrinology & Metabolism 100 (8), 2909-2917, 2015
Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss
EW Iepsen, J Lundgren, C Dirksen, JEB Jensen, O Pedersen, T Hansen, ...
International Journal of Obesity 39 (5), 834-841, 2015
Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3–36
EW Iepsen, J Lundgren, JJ Holst, S Madsbad, SS Torekov
European journal of endocrinology 174 (6), 775-784, 2016
A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased …
SS Torekov, T Harsløf, L Rejnmark, P Eiken, JB Jensen, AP Herman, ...
The Journal of Clinical Endocrinology & Metabolism 99 (4), E729-E733, 2014
Healthy weight loss maintenance with exercise, liraglutide, or both combined
JR Lundgren, C Janus, SBK Jensen, CR Juhl, LM Olsen, RM Christensen, ...
New England Journal of Medicine 384 (18), 1719-1730, 2021
Plasma proteome profiling reveals dynamics of inflammatory and lipid homeostasis markers after Roux-en-Y gastric bypass surgery
NJW Albrechtsen, PE Geyer, S Doll, PV Treit, KN Bojsen-Møller, ...
Cell systems 7 (6), 601-612. e3, 2018
Obesity–an indication for GLP‐1 treatment? Obesity pathophysiology and GLP‐1 treatment potential
SS Torekov, S Madsbad, JJ Holst
obesity reviews 12 (8), 593-601, 2011
Association between neuromedin U gene variants and overweight and obesity
I Hainerová, SS Torekov, J Ek, M Finková, K Borch-Johnsen, T Jørgensen, ...
The Journal of Clinical Endocrinology & Metabolism 91 (12), 5057-5063, 2006
KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia
SS Torekov, E Iepsen, M Christiansen, A Linneberg, O Pedersen, JJ Holst, ...
Diabetes 63 (4), 1315-1325, 2014
Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist
EW Iepsen, J Zhang, HS Thomsen, EL Hansen, M Hollensted, S Madsbad, ...
Cell metabolism 28 (1), 23-32. e3, 2018
Liraglutide for type 2 diabetes and obesity: a 2015 update
EW Iepsen, SS Torekov, JJ Holst
Expert review of cardiovascular therapy 13 (7), 753-767, 2015
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids
NJ Wewer Albrechtsen, K Færch, TM Jensen, DR Witte, J Pedersen, ...
Diabetologia 61 (3), 671-680, 2018
Glucose-dependent insulinotropic polypeptide is associated with lower low-density lipoprotein but unhealthy fat distribution, independent of insulin: the ADDITION-PRO study
CL Møller, D Vistisen, K Færch, NB Johansen, DR Witte, A Jonsson, ...
The Journal of Clinical Endocrinology & Metabolism 101 (2), 485-493, 2016
Therapies for inter-relating diabetes and obesity–GLP-1 and obesity
EW Iepsen, SS Torekov, JJ Holst
Expert opinion on pharmacotherapy 15 (17), 2487-2500, 2014
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20